Literature DB >> 16329096

Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.

Christina L Liquori1, Michel J Berg, Ferdinando Squitieri, Monica Ottenbacher, Marielle Sorlie, Tracey P Leedom, Milena Cannella, Vittorio Maglione, Louis Ptacek, Eric W Johnson, Douglas A Marchuk.   

Abstract

Cerebral cavernous malformations (CCMs) are vascular abnormalities of the brain that can result in a variety of neurological disabilities, including stroke and seizures. Linkage analyses using autosomal dominant families manifesting CCMs have identified three different causative loci on chromosomes 7q21.2 (CCM1), 7p13 (CCM2), and 3q25.2-q27 (CCM3). Mutations in the gene Krit1 are responsible for CCM1, mutations in the gene MGC4607 are responsible for CCM2, and mutations in the gene PDCD10 were recently reported to be responsible for CCM3. We report here that sequence analysis of PDCD10 in a panel of 29 probands lacking Krit1 and MGC4607 mutations revealed only three mutations. The frequency of identified mutations in the PDCD10 gene was surprisingly low, especially given that this panel was heavily biased towards non-CCM1, non-CCM2 probands. These data are in stark contrast with the linkage data, which suggests that 40% of inherited cases would be due to mutations in this gene. Interestingly, when examining the haplotypes of previously published CCM3 families, we found a distinct recombination event in one of the largest CCM3 families that excludes the PDCD10 gene. Although there are many potential explanations for this observation, when combined with the apparent under-representation of causative CCM mutations in PDCD10, this recombination event in a CCM3-linked family suggests that there may be an additional CCM gene in the same chromosomal region. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16329096     DOI: 10.1002/humu.9389

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  38 in total

1.  Multiple cerebral cavernous malformations and a novel CCM3 germline deletion in a German family.

Authors:  Chi-un Choe; Florence Riant; Christian Gerloff; Elisabeth Tournier-Lasserve; Michael Orth
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

Review 2.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

3.  CCM1 gene deletion identified by MLPA in cerebral cavernous malformation.

Authors:  Sabine Gaetzner; Sonja Stahl; Oguzkan Sürücü; Anne Schaafhausen; Birgit Halliger-Keller; Helmut Bertalanffy; Ulrich Sure; Ute Felbor
Journal:  Neurosurg Rev       Date:  2006-12-23       Impact factor: 3.042

Review 4.  Evaluating strategies for the treatment of cerebral cavernous malformations.

Authors:  Dean Y Li; Kevin J Whitehead
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 5.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 6.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

7.  PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival.

Authors:  Chengyi Lin; Shuxia Meng; Tina Zhu; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

8.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

Review 9.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Familial cerebral cavernous malformation: report of a further Italian family.

Authors:  Serena Nannucci; Francesca Pescini; Anna Poggesi; Laura Ciolli; Maria Cristina Patrosso; Alessandro Marocchi; Domenico Inzitari; Silvana Penco; Leonardo Pantoni
Journal:  Neurol Sci       Date:  2009-01-30       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.